Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Hidaka; Takayoshi
Address:
Kobe, JP
No. of patents:
23
Patents:












Patent Number Title Of Patent Date Issued
7754205 Composition for transmucosal administration containing conenzyme Q as the active ingredient July 13, 2010
The present invention relates to the supply of coenzyme Q which is highly useful in maintaining human health, and provides a method and preparations whereby coenzyme Q can be efficiently supplied to patients having difficulties in oral administration, aged having swallowing difficult
7364751 Stabilized compositions of aqueous reduced coenzyme Q solution April 29, 2008
The present invention provides a reduced coenzyme Q-containing solution capable of being retained more stably against oxidation, by using a reduced coenzyme Q which is hydrophobic and susceptible to oxidation and thus unstable.The aqueous solution containing a reduced coenzyme Q obta
7015252 Compositions for lessening oxidative stress March 21, 2006
The present invention provides an antioxidative composition with high safety, which is capable of lessening oxidative stress due to active oxygen species, free radicals, or the like in vivo, thereby preventing the occurrence or worsening of a disease. It was confirmed that by using a
6939897 Method and composition for inhibiting arteriosclerosis September 6, 2005
The present invention has for its object to provide a method and a composition for achieving a more efficient recovery of the antioxidant activity of plasma LDL, or even augmentation thereof, which has been depressed by the use of an antihyperlipidemic or cholesterol-lowering drug to
6362169 Antibacterial compositions with synergistic effect, drugs and remedies for digestive diseases co March 26, 2002
Antibacterial compositions comprising (1) a rifamycin derivative represented by the formula (I) or its physiologically acceptable salt, and (2) a proton pump inhibitor (a) or a bismuth preparation (b) wherein the components (1) and (2) are used in such amounts as producing a synergistic
6184255 Pharmaceutical composition comprising coenzyme Q10 February 6, 2001
The present invention has for its object to provide a medicinal composition comprising coenzyme Q.sub.10 as an active ingredient, which composition features an enhanced absorption after oral administration. The present invention is directed to a medicinal composition comprising coenzyme
6156802 Cholesterol-lowering composition December 5, 2000
The present invention has its object to provide an antihypercholesterolemic or antihyperlipidemic agent, hence a therapeutic and prophylactic drug for arteriosclerosis, which is safer and more potent in cholesterol-lowering action than the hitherto-available drugs.A cholesterol-lowering
5786349 Method for treating chlamydia infectious diseases by rifamycin derivative July 28, 1998
A method for treatment of diseases caused by Chlamydia infection is disclosed comprising administering a rifamycin of the formula (I): ##STR1## wherein R.sup.1 is hydrogen atom or acetyl, and X is oxygen, sulfur or a group NR, in which R is hydrogen, an alkyl group having 1 to 7 carb
5635486 Ophthalmic composition comprising a sleep adjusting substance June 3, 1997
The present invention provides an ophthalmic composition comprising a sleep inducing substance or a sleep inhibiting substance, and the sleep inducing substance or the sleep inhibiting substance is derived from an organism. Thus, the invention provides an ophthalmic composition comprisin
5556636 Adhesive composition for medical use September 17, 1996
The present invention is directed to a sticky composition for medical use comprising a tackifier resin and an oxyalkylene polymer having a silicon-containing group which can be crosslinked by forming a siloxane bond, wherein silicon atom thereof is bound with a hydroxyl group or hydr
5547683 Method for producing microgranulated particle August 20, 1996
The present invention relates to a method for producing a microgranulated particle having particle size of not more than 0.2 mm, wherein a fine powder with the average particle size of not more than 10 .mu.m, which is being agitated, tumbled or fluidized, is granulated, with a solution
5494917 Cognition enhancing quinuclidine compound February 27, 1996
A cognition enhancer comprising, as an effective ingredient, a bicyclic compound containing nitrogen atom having the general formula (I): ##STR1## or a physiologically acceptable salt thereof.
5298246 Stable pharmaceutical composition and method for its production March 29, 1994
The present invention is directed to a stable pharmaceutical composition wherein the absorbability of a lipophilic drug which is insoluble or practically insoluble in water or another drug such as a bioactive peptide in oral administration has been improved to such extent that a high lev
5270339 Phenoxybenzene derivative December 14, 1993
There are described a phenoxybenzene derivative having the formula (I): ##STR1## wherein R.sup.1 is hydrogen atom; an alkyl group having 1 to 3 carbon atoms; --OR.sup.6 or a halogen atom,R.sup.2 is hydrogen atom, nitro group or amino group,R.sup.3 is hydrogen atom, an alkyl group having
5268367 Composition and method for lowering blood level of LDL-cholesterol December 7, 1993
A cholesterol or body weight regulating material comprising an enzyme resistant starch is disclosed. A composition which contains said enzyme resistant starch is also disclosed. A food, food material, and beverage, containing said enzyme resistant starch are further disclosed. A method
5202341 Hydroxystyrene compounds having tyrosine kinase inhibiting activity April 13, 1993
A hydroxystyrene derivative represented by the formula (I): ##STR1## wherein when R.sup.1 and R.sup.2 : phenyl group, benzyl group or phenethyl group, or R.sup.1 : R.sup.5 O- (R.sup.5 : H, a C.sub.1 to C.sub.5 alkyl group or benzyl group) and R.sup.2 : benzyl group or PhSCH.sub.2, R.
5089516 1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have tyrosine kinase inhibiting ac February 18, 1992
A hydroxystyrene derivative represented by the formula (I): ##STR1## wherein when R.sup.1 and R.sup.2 : phenyl group, benzyl group or phenethyl group, or R.sup.1 : R.sup.5 O-- (R.sup.5 : H, a C.sub.1 to C.sub.5 alkyl group or benzyl group) and R.sup.2 : benzyl group or PhSCH.sub.2, R
5057538 Hydroxystyrene compounds which have useful pharmaceutical utility October 15, 1991
A hydroxystyrene derivative represented by the formula (I): ##STR1## Wherein when R.sup.1 and R.sup.2 : phenyl group, benzyl group or phenethyl group, or R.sup.1 : R.sup.5 O--(R.sup.5 : H, a C.sub.1 to C.sub.5 alkyl group or benzyl group) and R.sup.2 : benzyl group or PhSCH.sub.2, R.
4971996 Hydroxystyrene compounds which are useful as tyrosine kinase inhibitors November 20, 1990
A hydroxystyrene derivative represented by the formula (I): ##STR1## wherein when R.sup.1 and R.sup.2 : phenyl group, benzyl group or phenethyl group, or R.sup.1 : R.sup.5 O-- (R.sup.5 : H, a C.sub.1 to C.sub.5 alkyl group or benzyl group) and R.sup.2 : benzyl group or PhSCH.sub.2, R
4853403 3-phenylthiomethylstyrene derivative, process for preparing the same, and antiallergic agent and August 1, 1989
A 3-phenylthiomethylstyrene derivative having the general formula (1): ##STR1## or salt thereof with a base, when X is hydroxyl group, R.sup.1 is hydrogen atom or R.sup.2 is hydrogen atom, a process for preparing the 3-phenylthiomethylstyrene derivative (1), and an antiallergic agent
4440784 Anti-inflammatory, analgesic, and antipyretic pharmaceutical composition April 3, 1984
A new anti-inflammatory, analgesic, and antipyretic pharmaceutical composition is disclosed which contains a 3,5-di-tert-butyl-4-hydroxystyrene derivative of the formula: ##STR1## wherein R.sup.1 stands for a group represented by COR.sup.3 [R.sup.3 denotes a group of OR.sup.4 (R.
4431656 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing February 14, 1984
Novel compounds, 3,5-di-tert-butylstyrene derivatives and their salts, are disclosed, which derivatives are represented by the general formula: ##STR1## wherein R.sup.1 stands for an acyloxy group represented by R.sup.3 COO (R.sup.3 is a hydrogen atom or an alkyl group with C.sub.1 -
4259319 Antibiotic auromomycin, and process for production thereof March 31, 1981
A new antibiotic designated as auromomycin is prepared from the culture broth of Streptomyces macromomyceticus, a macromomycin-producing strain, as yellow crystals. Auromomycin is recovered in pure form from the culture broth by using hydrophobic chromatography with Octyl Sephalose CL-4B










 
 
  Recently Added Patents
Systems and methods for adaptive error thresholds or adaptive modulation schemes based on atmospheric conditions
NMR, instrumentation, and flow meter/controller continuously detecting MR signals, from continuously flowing sample material
Method and system for modifying satellite radio program subscriptions in a mobile vehicle
Tap and linking module TDO register, gating for TCK and TMS
Sericin cationic nanoparticles for application in products for hair and dyed hair
Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirusi in hexameric form
Multi-dimensional credibility scoring
  Randomly Featured Patents
Computer
Proportional solenoid-controlled fluid valve assembly without non-magnetic alignment support element
Heterocyclic compounds
Method of forming transistor having recess channel in semiconductor memory, and structure thereof
Centrifugal blower with axial clearance
Analysis apparatus
Beacon transmission techniques in directional wireless networks
Manhole cover
Electric valve actuator with eddy current clutch
Preparation of platinum(II) complexes